C12Y 301/02006
Hydroxyacylglutathione hydrolase
Official title: Hydroxyacylglutathione hydrolase (3.1.2.6)
C12Y301/02006 (Hydroxyacylglutathione hydrolase) appears on 4 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 4
- Assignees
- 4
- Inventors
- 9
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 2 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Phytase mutant2 Jun 2026US 12,644,106 B2Qingdao Vland Biotech Group Co., Ltd.
- Microbial approach for the production of long chain compounds10 Jun 2025US 12,325,859 B2University of Georgia Research Foundation, Inc.
- Phytase mutants29 Aug 2023US 11,739,336 B2Qingdao Vland Biotech Group Co., Ltd.
- Phytase mutants31 Aug 2021US 11,104,908 B2Qingdao Vland Biotech Group Co., Ltd.
- Phytase mutant3 Aug 2023US 2023/0242890 A1Qingdao Vland Biotech Group Co., Ltd.
- Microbial approach for the production of long chain compounds23 Feb 2023US 2023/0056452 A1University of Georgia Research Foundation, Inc.
- Phytase mutants27 Jan 2022US 2022/0025384 A1Qingdao Vland Biotech Group Co., Ltd.
- Phytase mutants19 Nov 2020US 2020/0362356 A1Qingdao Vland Biotech Group Co., Ltd.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.